References
Krassas GE, Gogakos A. Thyroid-associated ophthalmopathy in juvenile Graves’ disease—clinical, endocrine and therapeutic aspects. J Pediatr Endocrinol Metab. 2006;19:1193–206.
Durairaj VD, Bartley GB, Garrity JA. Clinical features and treatment of graves ophthalmopathy in pediatric patients. Ophthal Plast Reconstr Surg. 2006;22:7–12.
Nucci P, Brancato R, Bandello F, Alfarano R, Bianchi S. Normal exophthalmometric values in children. Am J Ophthalmol. 1989;108:582–4.
Goldstein SM, Katowitz WR, Moshang T, Katowitz JA. Pediatric thyroid-associated orbitopathy: the Children’s Hospital of Philadelphia experience and literature review. Thyroid. 2008;18:997–9.
Gianoukakis AG, Douglas RS, King CS, Cruikshank WW, Smith TJ. IgG from patients with Graves’ disease induces IL-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T cell infiltration of the thyroid in autoimmune disease. Endocrinology. 2006;147:1941–9.
Conflict of Interest
None.
Role of Funding Source
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dutta, D., Kumar, M., Mukhopadhyay, S. et al. Graves’ Orbitopathy Precipitated by Iatrogenic Hypothyroidism Secondary to Carbimazole for Graves’ Disease. Indian J Pediatr 81, 1244–1245 (2014). https://doi.org/10.1007/s12098-014-1443-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-014-1443-2